Janumet Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome
Condition:   PCOS Interventions:   Drug: Sitagliptin;   Behavioral: Lifestyle intervention Sponsor:   University Medical Centre Ljubljana Completed - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2017 Category: Research Source Type: clinical trials

Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea
Condition:   Uncontrolled Type 2 Diabetes Mellitus Interventions:   Drug: Sitagliptin 100mg;   Drug: Pioglitazone 30 mg Sponsor:   Tehran University of Medical Sciences Completed - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2017 Category: Research Source Type: clinical trials